Vial

Py , et al. September 14, 2

Patent Grant D623764

U.S. patent number D623,764 [Application Number D/352,911] was granted by the patent office on 2010-09-14 for vial. This patent grant is currently assigned to Medical Instill Technologies Inc.. Invention is credited to Norbert M. Assion, Julian V. Chan, Daniel Py.


United States Patent D623,764
Py ,   et al. September 14, 2010

Vial

Claims

CLAIM The ornamental design for a vial, as shown and described.
Inventors: Py; Daniel (Stamford, CT), Assion; Norbert M. (Shelton, CT), Chan; Julian V. (Spring Valley, NY)
Assignee: Medical Instill Technologies Inc. (New Milford, CT)
Appl. No.: D/352,911
Filed: December 29, 2009

Related U.S. Patent Documents

Application Number Filing Date Patent Number Issue Date
29330517 Jan 8, 2009 D607118
29303247 Feb 4, 2008 D585561
29265237 Aug 28, 2006 D561907
29198310 Jan 27, 2004 D527463

Current U.S. Class: D24/224
Current International Class: 2404
Field of Search: ;D24/224-226,215,121 ;D9/445,444,434,436,446,447,500-505,550,459 ;422/99-102 ;604/414-415 ;215/255,281,247,249 ;63/1R,1A,2 ;D99/324,346,34,43 ;D3/207-212,232,250,251

References Cited [Referenced By]

U.S. Patent Documents
1747983 February 1930 McCarthy
2503147 April 1950 Applezweig
2899050 August 1959 Collins
3092278 June 1963 Jarnhall
3340671 September 1967 Loo
D220718 May 1971 Pailet
3685248 August 1972 Godelaine
4171057 October 1979 Gach
4250611 February 1981 Wong
D263504 March 1982 Fowles et al.
4366812 January 1983 Matakura et al.
4390111 June 1983 Robbins et al.
D278600 April 1985 Fortuna
D279651 July 1985 Freeman
D281369 November 1985 Harris
4664275 May 1987 Kasai et al.
4703781 November 1987 Meyer et al.
4842028 June 1989 Kaufman et al.
D315095 March 1991 Wright
5085332 February 1992 Gettig et al.
5088612 February 1992 Storar et al.
5088995 February 1992 Packard et al.
5129212 July 1992 Duffey et al.
5247015 September 1993 Bayan
5341854 August 1994 Zezulka et al.
5344036 September 1994 Stanescu et al.
5379908 January 1995 Rohe
5411065 May 1995 Meador et al.
5464111 November 1995 Vacek et al.
5484566 January 1996 Gabbard
5514339 May 1996 Leopardi et al.
5549141 August 1996 Meador et al.
5603401 February 1997 Brunner
5641004 June 1997 Py
D383214 September 1997 Brennan
D389586 January 1998 Brennan
D390000 February 1998 Savas
5718348 February 1998 Manera
5744087 April 1998 Williams et al.
5816772 October 1998 Py
5823373 October 1998 Sudo et al.
5902298 May 1999 Niedospial et al.
5931828 August 1999 Durkee
5971181 October 1999 Niedospial, Jr. et al.
6006932 December 1999 Morin
D420744 February 2000 Ostgaard et al.
6068150 May 2000 Mitchell et al.
6070748 June 2000 Sotrar
6095355 August 2000 Jessen et al.
6145688 November 2000 Smith
D434980 December 2000 Suzuki
D439345 March 2001 Herchenbach et al.
D443126 May 2001 Reviea et al.
6223918 May 2001 Browne
6234335 May 2001 Gee et al.
6382441 May 2002 Carano
D483030 December 2003 Melton
D485365 January 2004 Py et al.
D505494 May 2005 Py et al.
D522663 June 2006 Py et al.
D527463 August 2006 Py et al.
D533670 December 2006 Py et al.
D543411 May 2007 Rittberg
D561907 February 2008 Py et al.
D561908 February 2008 Py et al.
D568094 May 2008 Cohen et al.
D573401 July 2008 Cohen et al.
D585561 January 2009 Py et al.
7568509 August 2009 Py
2001/0041872 November 2001 Paul, Jr.
2002/0010995 January 2002 Thibault et al.
2002/0023893 February 2002 Sudo et al.
2002/0029022 March 2002 Naritomi et al.
Primary Examiner: Brooks; Cathron C
Assistant Examiner: Levy; Melanie
Attorney, Agent or Firm: McCarter & English, LLP

Description



FIG. 1 is a top perspective view of a first embodiment of a vial showing our new design;

FIG. 2 is a front elevational view of the vial of FIG. 1;

FIG. 3 is a rear elevational view thereof;

FIG. 4 is a left side elevational view thereof;

FIG. 5 is a right side elevational view thereof;

FIG. 6 is a top plan view thereof; and,

FIG. 7 is a bottom plan view thereof.

The broken lines in the figures show structure or boundaries that are not part of the claimed design, but rather show the environment in which the design is associated, or show portions of the article in which the design is embodied or applied to that are not considered part of the claimed design. The diagonal lines (or shading lines) are intended to show that the respective portion(s) of the vial are transparent or substantially transparent, whereas the claimed portion(s) of the vial that do not include such lines are opaque or substantially opaque.

* * * * *


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed